Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Whole Genome And Exome Sequencing Market Size Likely To Evolve From 2025 Through 2034?
The whole genome and exome sequencing market size has experienced significant expansion in recent years. This market is anticipated to grow from $2.02 billion in 2024 to $2.52 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 24.5%. Historically, this growth can be ascribed to elements such as decreasing sequencing costs, an uptick in genetic disorders, diverse clinical applications, the development of genomic data repositories, and advancements in bioinformatics.
The whole genome and exome sequencing market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a valuation of $6.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 24.8%. This projected increase within the forecast period is attributable to population genomics initiatives, a growing demand for precision medicine, advancements in single-cell sequencing, the proliferation of non-invasive prenatal testing (NIPT), and its utility in rare disease research. Prominent trends for the forecast period encompass broader clinical acceptance, rapid progress in sequencing technologies, the advent of population-scale genomic studies, the integration of artificial intelligence (AI) and machine learning (ML), and expanding applications within oncology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
What Are The Drivers Pushing New Developments In The Whole Genome And Exome Sequencing Market?
The future growth of the whole genome and exome sequencing market is anticipated to be driven by the escalating demand for personalized medicine. Personalized medicine represents a healthcare approach that tailors medical decisions and interventions to the individual characteristics of each patient, considering their genetics, environment, and lifestyle. Whole genome and exome sequencing plays a crucial role in personalized medicine by offering a comprehensive analysis of an individual’s genetic makeup, thereby enabling customized healthcare decisions and interventions based on their unique genetic, environmental, and lifestyle factors. For example, in October 2022, the Personalized Medicine Coalition (PMC), a US-based organization focused on promoting personalized medicine, reported that more than 75,000 genetic testing products and 300 personalized medicines were expected on the market in 2022. Furthermore, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Among these, approximately 34% of the 35 therapeutic NMEs, totaling 12, were classified as personalized. Thus, the increasing demand for personalized medicine is significantly boosting the growth of the whole genome and exome sequencing market.
What Are The Primary Types Of Segments Analyzed In The Whole Genome And Exome Sequencing Market?
The whole genome and exome sequencingmarket covered in this report is segmented –
1) By Product Type: Kits; Instruments
2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems
What Key Innovation Trends Are Fueling Advancements In The Whole Genome And Exome Sequencing Market?
Major companies engaged in the whole genome and exome sequencing markets are intensifying their efforts to develop advanced technological solutions, such as ultra-fast NGS (next-generation sequencing) analysis, aiming to secure a competitive advantage. Ultra-fast NGS analysis is a technological advancement that allows for the processing of next-generation sequencing (NGS) data at an exceptionally rapid pace, substantially reducing the time needed for genomic data analysis. For instance, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, introduced its ultra-fast NGS analysis platform. This platform provides features like processing a whole genome in 25 minutes for $1 in cloud computing costs, thereby fostering efficiency, affordability, and scalability. Its technological innovation significantly boosts genomic data analysis speed and accessibility, making it considerably important in the whole genome and exome sequencing market by enabling swift decision-making and broader adoption of personalized medicine.
Who Are The Top Performing Companies In The Whole Genome And Exome Sequencing Market In Recent Years?
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Whole Genome And Exome Sequencing Market During The Forecast Period?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Whole Genome And Exome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp
Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2025, By The Business Research Company
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Prenatal Dna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report
Whole Exome Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model